Media

Oncopeptides to host Capital Markets Update featuring leading global experts in Multiple Myeloma

Doctrin receives MDR certification under class IIa

SynOx Therapeutics Strengthens Board of Directors with Leading Experts in Commercialisation and Corporate Development Amid Continued Corporate Progress

Kivu Bioscience Presents Preclinical Data for KIVU-107 Demonstrating Potent and Durable Anti-Tumor Activity and a Wide Therapeutic Index at World ADC San Diego 2025

Oncopeptides – Journal of Cancer Research and Clinical Oncology: Exceptional long-term responses to Pepaxti

Aprea Therapeutics Establishes Recommended Phase 2 Dose (RP2D) for ATRN-119, Considering Combination Therapies

Ariceum Therapeutics and Nusano Announce Multi-Isotope Supply Agreement

Intervacc and Dechra extend distribution agreement for Intervacc’s equine strangles vaccine Strangvac by two years

Adcendo ApS Announces FDA Fast Track Designation Granted to ADCE-D01 for the Treatment of Soft Tissue Sarcoma

Spruce Biosciences Announces $50.0 Million Private Placement Financing